PULM
PULM
NASDAQ · Pharmaceuticals

Pulmatrix Inc

$1.43
+0.03 (+2.14%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +217.5% upside
Low Target $3.16
Average Target $4.54
High Target $6.69
Current Price $1.43
Current
$1.43
Target
$4.54
$3.16 $4.54 avg $6.69
Scenario Analysis
Bear Case
$3.16
121.0%
Low target
Base Case
$4.54
+217.5%
Avg target
Bull Case
$6.69
+367.8%
High target
Risk/Reward
3.0x
Highly favorable
Price in Context
52-Week High
$4.99
-71.3% from high
52-Week Low
$1.16
+23.3% from low
Target vs 52W High
$4.54
-9.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.8%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +9.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.3%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.7%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +177.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +163.0%